Back
EyePoint Pharmaceuticals Stock Price Chart
Sell
50
EYPT
EyePoint Pharmaceuticals
Last Price:
11.83
Seasonality Move:
6.87%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
EyePoint Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.29 | Sell |
20-day SMA: | 14.91 | Sell |
50-day SMA: | 18.8 | Sell |
200-day SMA: | 16.41 | Sell |
8-day EMA: | 12.77 | Sell |
20-day EMA: | 14.74 | Sell |
50-day EMA: | 17.9 | Sell |
200-day EMA: | 16.83 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.16 | Sell |
Relative Strength Index (14 RSI): | 33.49 | Sell |
Chaikin Money Flow: | -950333 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.51 - 19.29) | Sell |
Bollinger Bands (100): | (17.37 - 26.89) | Sell |
EyePoint Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 11.84 while EYPT 8-day simple moving average is 12.29, which is a Sell signal.
- The stock price of EYPT is 11.84 while EyePoint Pharmaceuticals 20-day SMA is 14.91, which makes it a Sell.
- EyePoint Pharmaceuticals 50-day simple moving average is 18.80 while EYPT share price is 11.84, making it a Sell technically.
- EYPT stock price is 11.84 and EyePoint Pharmaceuticals 200-day simple moving average is 16.41, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Sell
50
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a Sell
The current EyePoint Pharmaceuticals [EYPT] share price is $11.84. The Score for EYPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
616.68M
Price in USD:
11.84
Share Volume:
1.04M
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
5.67
Sell
50
EyePoint Pharmaceuticals (EYPT)
is a Sell
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?
The EyePoint Pharmaceuticals stock price is 11.84 USD today. -
Will EYPT stock go up or go down?
EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is EyePoint Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 11.84 while EYPT 8-day exponential moving average is 12.77, which is a Sell signal.
- The stock price of EYPT is 11.84 while EyePoint Pharmaceuticals 20-day EMA is 14.74, which makes it a Sell.
- EyePoint Pharmaceuticals 50-day exponential moving average is 17.90 while EYPT share price is 11.84, making it a Sell technically.
- EYPT stock price is 11.84 and EyePoint Pharmaceuticals 200-day simple moving average is 16.83, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.85 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
- EYPT Moving Average Covergence Divergence (MACD) indicator is -2.16, suggesting EyePoint Pharmaceuticals is a Sell
- EyePoint Pharmaceuticals Relative Strength Index (RSI) is 33.49, which suggest EyePoint Pharmaceuticals is oversold
- The Bollinger Bands (25) for EyePoint Pharmaceuticals is (12.51 - 19.29), which suggest EyePoint Pharmaceuticals is a Sell
- The Bollinger Bands (100) for EyePoint Pharmaceuticals is (17.37 - 26.89), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.